This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: University of Michigan. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: The Innovative Work of Omolola Eniola-Adefeso
Introduction
Omolola Eniola-Adefeso is a distinguished inventor based in Ann Arbor, MI, who has made significant contributions to the field of biomedical engineering. With two patents to her name, her groundbreaking research focuses on leveraging polymer particles to enhance therapeutic strategies for neutrophil-related disorders.
Latest Patents
Among her noteworthy patents is the invention of polymer particles designed to restrain neutrophil function. These innovative polymer particles are aimed at preventing, treating, and ameliorating a range of inflammatory diseases, infections, autoimmune diseases, malignant diseases, and other conditions where neutrophils play a critical role. In addition, the patent includes methods for diagnosing neutrophil-related diseases or conditions, underscoring the potential impact of her work in medical diagnostics and treatment.
Career Highlights
Eniola-Adefeso is affiliated with the University of Michigan, where she actively engages in research that combines engineering principles with medical applications. Her work reflects an impressive intersection of innovation and science, making her a prominent figure within her field.
Collaborations
Throughout her career, she has collaborated with notable colleagues such as William N. Kelley and Theodore Standiford. These partnerships not only enhance the scope of her research but also drive advancements in the treatment of debilitating conditions linked to neutrophils.
Conclusion
Omolola Eniola-Adefeso exemplifies the advancements being made at the intersection of engineering and medicine. Her patents demonstrate innovative approaches to managing and diagnosing neutrophil-related diseases, marking her as a pivotal contributor to healthcare innovation. As her research continues, the impact of her work promises to significantly improve therapeutic outcomes for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

